Research Takeaway: I received heart-damaging treatment. How often do I need an echocardiogram?

Recent research underscores the importance of monitoring heart health before and after chemotherapy, especially for patients undergoing heart-damaging (cardiotoxic) treatments such as anthracyclines or trastuzumab. A 2025 study followed over 800 breast cancer survivors for an average of eight years. The researchers found that cardiac dysfunction increased over time, from 1.8% at two years after treatment to 15.3% at 15 years.

.

Repurposed Drugs in Cancer Care

With widespread access to cancer research studies and anecdotal stories through internet searches and social media, people with cancer are becoming increasingly proactive in exploring all available treatment options. This trend has spurred grassroots adoption of complex supplement regimens and repurposed drug protocols. The fact that there is some evidence for various repurposed drugs to improve cancer outcomes makes it tempting for individuals to assume these drugs will help their cancer.

.

Fenbendazole and Cancer: A Closer Look at Its Use and Risks

CancerChoices reviews and synthesizes the evidence behind complementary therapies including repurposed drugs. Given the significant interest in our review of Mebendazole and Fenbendazole, and our accompanying article on repurposed drugs, we’ve partnered with Mark Taylor of Patient Led Oncology to provide a deeper analysis of Fenbendazole.  

.

Meet the Practitioner: Dr. Linda E. Carlson, Psychosocial Oncology

Dr. Linda Carlson is a globally recognized leader in psychosocial and integrative oncology, specializing in developing and evaluating complementary therapies to improve the lives of people with cancer. These include mindfulness-based programs, yoga, acupuncture and creative therapies. Known for her research creativity and productivity, she blends cutting-edge research with clinical expertise to advance holistic cancer […]

.

Life Over Cancer: A New Model of Integrative Cancer Treatment with Keith Block, MD

In this webinar, CancerChoices co-founder Michael Lerner converses with CancerChoices advisor Keith Block, MD—long regarded as the “father” of integrative oncology—about his model for integrative cancer treatment.

.

Easing Cancer Pain and Suffering with Tom Smith, MD

In this CancerChoices webinar, CancerChoices co-founder Michael Lerner and Thomas Smith, MD, converse about easing cancer pain and suffering. Uncontrolled pain creates unnecessary suffering, but when pain is controlled, quality of life improves dramatically.

.

Your Dance with Cancer: A Conversation with A Metastatic Breast Cancer Thriver

In this CancerChoices webinar, CancerChoices co-founder Michael Lerner talks with cancer coach Lindsay McDonell about her journey with cancer, her coaching work, and her work with the Smith Center for Healing and the Arts in Washington, DC.

.

Catching up to the Science of Cancer Care with Wayne Jonas, MD

In this CancerChoices webinar, CancerChoices co-founder Michael Lerner and CancerChoices advisor Wayne B. Jonas, MD, explore how whole person care can become part of routine oncology.

.

Three Surprisingly Effective Complementary Cancer Therapies: Aspirin, Vitamin D, and Melatonin

In this CancerChoices webinar, Michael Lerner, Nancy Hepp, and Laura Pole, MSN, RN, OCNS of CancerChoices explore the good evidence of effectiveness for improving survival and reducing risk of cancer for three complementary therapies.

.

What Matters Now: Reflective Questions for Life After a Cancer Diagnosis

Exploring the question, “what matters now” may help us find what most needs healing in our lives. This exploration leads to deeper questions on how we wish to live after a life changing diagnosis.

.
Next page